首页> 外文OA文献 >Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes
【2h】

Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes

机译:磷脂醛与醛酮还原酶的底物特异性和催化效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phospholipid oxidation generates several bioactive aldehydes that remain esterified to the glycerol backbone (‘core’ aldehydes). These aldehydes induce endothelial cells to produce monocyte chemotactic factors and enhance monocyte–endothelium adhesion. They also serve as ligands of scavenger receptors for the uptake of oxidized lipoproteins or apoptotic cells. The biochemical pathways involved in phospholipid aldehyde metabolism, however, remain largely unknown. In the present study, we have examined the efficacy of the three mammalian AKR (aldo-keto reductase) families in catalysing the reduction of phospholipid aldehydes. The model phospholipid aldehyde POVPC [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine] was efficiently reduced by members of the AKR1, but not by the AKR6 or the ARK7 family. In the AKR1 family, POVPC reductase activity was limited to AKR1A and B. No significant activity was observed with AKR1C enzymes. Among the active proteins, human AR (aldose reductase) (AKR1B1) showed the highest catalytic activity. The catalytic efficiency of human small intestinal AR (AKR1B10) was comparable with the murine AKR1B proteins 1B3 and 1B8. Among the murine proteins AKR1A4 and AKR1B7 showed appreciably lower catalytic activity as compared with 1B3 and 1B8. The human AKRs, 1B1 and 1B10, and the murine proteins, 1B3 and 1B8, also reduced C-7 and C-9 sn-2 aldehydes as well as POVPE [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphoethanolamine]. AKR1A4, B1, B7 and B8 catalysed the reduction of aldehydes generated in oxidized C16:0-20:4 phosphatidylcholine with acyl, plasmenyl or alkyl linkage at the sn-1 position or C16:0-20:4 phosphatidylglycerol or phosphatidic acid. AKR1B1 displayed the highest activity with phosphatidic acids; AKR1A4 was more efficient with long-chain aldehydes such as 5-hydroxy-8-oxo-6-octenoyl derivatives, whereas AKR1B8 preferred phosphatidylglycerol. These results suggest that proteins of the AKR1A and B families are efficient phospholipid aldehyde reductases, with non-overlapping substrate specificity, and may be involved in tissue-specific metabolism of endogenous or dietary phospholipid aldehydes.
机译:磷脂氧化产生了几种生物活性醛,这些醛仍被酯化为甘油骨架(“核心”醛)。这些醛诱导内皮细胞产生单核细胞趋化因子,并增强单核细胞与内皮的粘附。它们还充当清除剂受体的配体,用于摄取氧化的脂蛋白或凋亡细胞。但是,涉及磷脂醛代谢的生化途径仍然未知。在本研究中,我们检查了三个哺乳动物AKR(醛酮还原酶)家族在催化磷脂醛还原方面的功效。模型磷脂醛POVPC [1-棕榈酰基-2-(5-氧戊酰基)-sn-甘油-3-磷酸胆碱]被AKR1成员有效还原,但未被AKR6或ARK7家族还原。在AKR1家族中,POVPC还原酶的活性仅限于AKR1A和B。使用AKR1C酶未观察到明显的活性。在活性蛋白中,人AR(醛糖还原酶)(AKR1B1)显示出最高的催化活性。人类小肠AR(AKR1B10)的催化效率与鼠AKR1B蛋白1B3和1B8相当。在鼠蛋白中,AKR1A4和AKR1B7与1B3和1B8相比显示出明显较低的催化活性。人AKR 1B1和1B10以及鼠类蛋白1B3和1B8还还原了C-7和C-9 sn-2醛以及POVPE [1-棕榈酰基-2-(5-氧代戊酰)-sn-甘油-3-磷酸乙醇胺]。 AKR1A4,B1,B7和B8催化还原在氧化的C16:0-20:4磷脂酰胆碱中生成的醛,该磷脂在sn-1位置带有酰基,纤溶基或烷基键或C16:0-20:4磷脂酰甘油或磷脂酸。 AKR1B1对磷脂酸显示出最高的活性; AKR1A4对于长链醛(例如5-羟基-8-氧代-6-辛烯酰基衍生物)更有效,而AKR1B8优选磷脂酰甘油。这些结果表明,AKR1A和B家族的蛋白质是有效的磷脂醛还原酶,具有不重叠的底物特异性,并且可能参与内源性或膳食磷脂醛的组织特异性代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号